We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
351
Chipotle Mexican Grill
CMG
$43.7B
$425K 0.07%
15,300
-3,200
-17% -$95.6K
VMC icon
352
Vulcan Materials
VMC
$37.2B
$422K 0.07%
2,408
+737
+44% +$126K
LOPE icon
353
Grand Canyon Education
LOPE
$3.92B
$417K 0.07%
3,945
-1,561
-28% -$156K
BEAM icon
354
Beam Therapeutics
BEAM
$2.8B
$416K 0.07%
10,640
-4,815
-31% -$216K
WIRE
355
DELISTED
Encore Wire Corp
WIRE
$416K 0.07%
3,022
-414
-12% -$57.3K
CFR icon
356
Cullen/Frost Bankers
CFR
$10.3B
$411K 0.07%
+3,077
New +$437K
DOCS icon
357
Doximity
DOCS
$3.94B
$410K 0.07%
+12,206
New +$373K
JPM icon
358
JPMorgan Chase
JPM
$955B
$405K 0.07%
+3,020
New +$383K
HUN icon
359
Huntsman Corp
HUN
$1.78B
$400K 0.07%
+14,540
New +$396K
OLN icon
360
Olin
OLN
$2.13B
$398K 0.07%
+7,524
New +$399K
NOV icon
361
NOV
NOV
$6.95B
$393K 0.07%
18,834
-18,412
-49% -$386K
MSGS icon
362
Madison Square Garden
MSGS
$9.42B
$390K 0.07%
2,126
-1,283
-38% -$201K
NDSN icon
363
Nordson
NDSN
$17.3B
$389K 0.07%
1,636
+403
+33% +$92K
ZM icon
364
Zoom
ZM
$29.5B
$388K 0.07%
+5,726
New +$435K
NEOG icon
365
Neogen
NEOG
$2.49B
$386K 0.07%
25,375
-53,267
-68% -$759K
CPRI icon
366
Capri Holdings
CPRI
$1.84B
$385K 0.07%
6,710
-6,688
-50% -$338K
RRX icon
367
Regal Rexnord
RRX
$12.2B
$385K 0.07%
3,205
+1,044
+48% +$137K
AMC icon
368
AMC Entertainment Holdings
AMC
$2.38B
$384K 0.07%
+9,441
New +$595K
XYZ
369
Block Inc
XYZ
$50.1B
$384K 0.07%
6,107
-29,063
-83% -$1.79M
EQT icon
370
EQT Corp
EQT
$32B
$379K 0.06%
11,202
-66,527
-86% -$2.67M
IRT icon
371
Independence Realty Trust
IRT
$4.03B
$378K 0.06%
22,429
-5,306
-19% -$89.8K
NDAQ icon
372
Nasdaq
NDAQ
$52.9B
$378K 0.06%
6,159
+242
+4% +$15.1K
FRSH icon
373
Freshworks
FRSH
$3.18B
$377K 0.06%
25,650
-937
-4% -$13K
NXST icon
374
Nexstar Media Group
NXST
$5.8B
$377K 0.06%
+2,153
New +$378K
MDB icon
375
MongoDB
MDB
$30.3B
$374K 0.06%
1,898
-262
-12% -$46.6K

Similar funds

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.